June 21, 2025
A new evidence-based review challenges common public health claims about myocarditis related to COVID-19 infection versus mRNA vaccines.
The authors examined clinical trials, observational studies, and post-marketing data and concluded that mRNA COVID-19 vaccines are more strongly associated with myocarditis than the virus itself—particularly among males under 40. Contrary to earlier reassurances, the paper argues that vaccine-related myocarditis is not always mild or short-lived and may have lasting effects.
Given these findings, the authors call for the removal of mRNA COVID-19 vaccines from the market, citing a risk-benefit profile that no longer supports their use in the general population.
Reference HERE.